Key facts
- This page summarizes Martin Lamb's Form 4 filing for Evoqua Water Technologies Corp..
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 May 2023, 16:45.
Martin Lamb - 24 May 2023 Form 4 Insider Report for Evoqua Water Technologies Corp.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 24 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 May 2023, 16:45:46 UTC
- Prior SEC filing
- 09 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John DiMascio, Attorney-in-Fact for Martin Lamb
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Martin Lamb filed Form 4 for Evoqua Water Technologies Corp. on 26 May 2023.
Change
- Previous filing in this sequence was filed on 09 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AQUA
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -16,239
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 24 May 2023
- Ownership
- Direct
- Footnotes
- F1
AQUA
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -49,711
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 24 May 2023
- Ownership
- By Trust
- Footnotes
- F2, F3
AQUA
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -40,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 24 May 2023
- Ownership
- By FIC
- Footnotes
- F2, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AQUA
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- Shares
- -44,903
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 24 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 44,903
- Exercise price
- $4.64
- Footnotes
- F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Martin Lamb is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 6 footnotes
Footnote F1
Disposed of pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023. Upon effectiveness of the merger on May 24, 2023, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") were converted into RSUs for Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share.
Footnote F2
Disposed of upon effectiveness of the merger, in which each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares.
Footnote F3
Shares held by a Bare trust, for the benefit of the reporting person's immediate family members and for which the reporting person retains investment control.
Footnote F4
Shares held by an FIC, for which the reporting person retains investment control. The reporting person disclaims beneficial ownership with respect to these securities except to the extent of his pecuniary interest therein.
Footnote F5
This option is fully vested. Pursuant to the merger agreement, each unexercised option to purchase issuer common stock was assumed by Xylem and converted into an option to purchase Xylem common shares. The number of Xylem common shares subject to the Xylem option is equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share.
Footnote F6
Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent.